Amarna Therapeutics
Manufacturing · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
J.h. Oortweg 21, Leiden, South Holland, ...Phone Number
+31 647566999Website
www.amarnatherapeutics.comRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Amarna Therapeutics
Amarna Therapeutics specializes in next-generation gene therapy, utilizing a non-immunogenic viral platform to deliver transgenes into humans. The company is focused on developing transformative gene therapies for various diseases, including type 1 diabetes, multiple sclerosis, and age-related macular degeneration. Their innovative approach aims to address both rare and prevalent conditions, particularly in the areas of monogenetic disorders, autoimmune diseases, and chronic inflammation. Amarna Therapeutics is committed to advancing its pipeline towards clinical trials to unlock the potential of these therapies.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amarna Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Amarna Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Amarna Therapeutics has new funding data
Click to see if Amarna Therapeutics had a recent Job posting/layoffs
Amarna Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Amarna Therapeutics launches new products
Check out if Amarna Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Amarna Therapeutics
Earning: See what the market has to say on Amarna Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Amarna Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amarna Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amarna Therapeutics.
Amarna Therapeutics financials insights
Gather financial insights about Amarna Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Other Financing Round
$11M
Amarna Therapeutics Tech Stack
A closer look at the technologies used by Amarna Therapeutics
Most Recent Scoops
Project
Product Development, Research & Development, Medical Research, Pharmaceuticals, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Promotion
Executive Move
New Hire
Executive Move
New Hire
Amarna Therapeutics News & Media
Phenocell and Amarna Therapeutics Awarded Eurostars Grant to Assess a Gene Therapy for Dry AMD using a novel 3-dimensional iPSC-derived Retinal Model of the Disease
Grasse, France and Leiden, the Netherlands – 11 December 2024 – Phenocell SAS (part of Axol Bioscience) a leading provider of stem cell-derived models...Amarna Therapeutics Partners with NorthX Biologics to Advance Nimvec™ AM510 Gene Therapy Development
Amarna Therapeutics Partners with NorthX Biologics to Advance Nimvec™ AM510 Gene Therapy DevelopmentAmarna Therapeutics Secures Regulatory Guidance From FDA for Diabetes Gene Therapy AM510
Amarna noted that the meeting, which took place on July 31, 2024, provided the company with feedback on the overall development plan for AM510.Amarna Therapeutics Receives Constructive Feedback from FDA INTERACT Meeting for AM510 Gene Therapy Development Targeting Type 1 Diabetes
Amarna Therapeutics Receives Constructive Feedback from FDA INTERACT Meeting for AM510 Gene Therapy Development Targeting Type 1 Diabetes
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amarna Therapeutics
Sign Up For FreeTo access detailed company insights
Amarna Therapeutics specializes in next-generation gene therapy, utilizing a non-immunogenic viral platform to deliver transgenes into humans. The company is focused on developing transformative gene therapies for various diseases, including type 1 diabetes, multiple sclerosis, and age-related macular degeneration. Their innovative approach aims to... Read More
